Financials in USD. Standardized financial statements.
A compact view of how Yield10 Bioscience, Inc. turns revenue into operating income and net income.
| Metric | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 | FY 2015 | FY 2014 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue? | $60,000 | $450,000 | $614,000 | $799,000 | $806,000 | $556,000 | $944,000 | $1.16M | $2.59M | $2.80M |
| Revenue Growth? | -86.7% | -26.7% | -23.2% | -0.9% | +45.0% | -41.1% | -18.6% | -55.3% | -7.4% | 0.0% |
| Cost of Revenue? | $290,000 | $656,000 | $578,000 | $5.22M | $4.85M | $4.78M | $4.60M | $5.67M | $660,000 | $1.48M |
| Gross Profit? | -$230,000 | -$206,000 | $36,000 | -$4.42M | -$4.04M | -$4.23M | -$3.65M | -$4.51M | $1.93M | $1.32M |
| Gross Margin? | -383.3% | -45.8% | +5.9% | -553.3% | -501.5% | -760.3% | -387.0% | -389.2% | +74.6% | +47.1% |
| Operating Expenses? | $14.48M | $13.90M | $12.31M | $10.41M | $9.40M | $9.88M | $10.23M | $11.41M | $25.68M | $28.15M |
| Operating Income? | -$14.42M | -$13.45M | -$11.69M | -$9.61M | -$8.60M | -$9.32M | -$9.28M | -$10.25M | -$23.74M | -$26.83M |
| EBITDA? | -$14.13M | -$13.19M | -$11.47M | -$9.43M | -$8.39M | -$9.12M | -$9.08M | -$10.07M | -$12.35M | -$26.32M |
| Income Before Tax | -$14.46M | -$13.41M | -$10.99M | -$10.15M | -$13.21M | -$9.19M | -$9.40M | -$10.29M | -$23.68M | -$26.77M |
| Income Tax Expense | $0 | $156,000 | $36,000 | $56,000 | -$254,000 | $0 | $0 | -$1.10M | -$62,000 | $0 |
| Net Income? | -$14.46M | -$13.57M | -$11.03M | -$10.21M | -$12.96M | -$9.19M | -$9.40M | -$7.60M | -$23.68M | -$29.53M |
| EPS? | $-43.66 | $-66.25 | $-55.95 | $-103.21 | $-851.98 | $-887.78 | $-2771.06 | $-2651.74 | $-9184.37 | $-27966.30 |
| Diluted EPS? | $-43.66 | $-66.25 | $-55.95 | $-103.21 | $-851.98 | $-887.78 | $-2771.06 | $-2651.74 | $-9184.37 | $-27966.30 |
Revenue, profitability, margins, EPS, and share-count trends over time.
Top-line demand and scale over time
Profit left after direct production costs
Core business profitability before financing and tax
Bottom-line profit after all expenses
Profit allocated to each diluted share
Share count trend that affects EPS quality
Gross, operating, and net margin quality